Regenerex Pharma (RGPX) Total Debt (2017 - 2024)

Regenerex Pharma (RGPX) has 8 years of Total Debt data on file, last reported at $184232.0 in Q1 2024.

• Total Debt for Q1 2024 came in at $184232.0, up 39.69% year-over-year; the trailing twelve-month figure through Mar 2024 was $184232.0 (up 39.69% YoY), and the FY2024 annual result was $184232.0, up 39.69% from the prior year.
• Total Debt improved to $184232.0 in Q1 2024 per RGPX's latest filing, from $2800.0 in the prior quarter.
• Over five years, Total Debt peaked at $184232.0 in Q1 2024 and troughed at $100.0 in Q4 2021.
• A 5-year average of $109494.6 and a median of $130992.0 in 2020 frame the typical range for Total Debt.
• The sharpest annual moves came in 2022 and 2023: Total Debt jumped 131787.0% in 2022, then tumbled 97.99% in 2023.
• A 5-year view of Total Debt shows it stood at $130992.0 in 2020, then plunged by 99.92% to $100.0 in 2021, then jumped by 131787.0% to $131887.0 in 2022, then slumped by 97.88% to $2800.0 in 2023, then surged by 6479.71% to $184232.0 in 2024.
• Business Quant data shows RGPX's Total Debt at $184232.0 in Q1 2024, $2800.0 in Q4 2023, and $2800.0 in Q3 2023.